These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19525900)

  • 21. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.
    Donckier V; Craciun L; Lucidi V; Buggenhout A; Troisi R; Rogiers X; Boon N; Gustot T; Moreno C; Bourgeois N; Colle I; Van Vlierberghe H; Nagy N; Praet M; Dernies T; Amrani M; Stordeur P; de Hemptinne B; Goldman M
    Transplantation; 2009 May; 87(9 Suppl):S91-5. PubMed ID: 19424019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
    Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
    Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
    Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
    J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host.
    Liu XS; Leerberg J; MacDonald K; Leggatt GR; Frazer IH
    J Immunol; 2009 Jul; 183(1):51-8. PubMed ID: 19535638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
    Li CH; Jiao BH
    Ai Zheng; 2007 Jan; 26(1):38-43. PubMed ID: 17222365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
    Tang L; Hu HD; Hu P; Lan YH; Peng ML; Chen M; Ren H
    Gene Ther; 2007 Aug; 14(16):1226-34. PubMed ID: 17597794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
    Lichtor T; Glick RP; Tarlock K; Moffett S; Mouw E; Cohen EP
    Cancer Gene Ther; 2002 May; 9(5):464-9. PubMed ID: 11961669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators.
    Nejat S; Zaki A; Hirsch GM; Lee TD
    Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
    Steers NJ; Peachman KK; McClain S; Alving CR; Rao M
    Vaccine; 2009 Nov; 27(49):6939-49. PubMed ID: 19748578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
    Fritzell S; Eberstål S; Sandén E; Visse E; Darabi A; Siesjö P
    J Neuroimmunol; 2013 May; 258(1-2):91-5. PubMed ID: 23528658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism.
    Fan TM; Kranz DM; Roy EJ
    J Immunother; 2007; 30(5):479-89. PubMed ID: 17589288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells.
    Cheadle EJ; Hawkins RE; Batha H; Rothwell DG; Ashton G; Gilham DE
    J Immunother; 2009 Apr; 32(3):207-18. PubMed ID: 19242379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.
    Sonabend AM; Velicu S; Ulasov IV; Han Y; Tyler B; Brem H; Matar MM; Fewell JG; Anwer K; Lesniak MS
    Anticancer Drugs; 2008 Feb; 19(2):133-42. PubMed ID: 18176109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
    Pellegatta S; Poliani PL; Corno D; Menghi F; Ghielmetti F; Suarez-Merino B; Caldera V; Nava S; Ravanini M; Facchetti F; Bruzzone MG; Finocchiaro G
    Cancer Res; 2006 Nov; 66(21):10247-52. PubMed ID: 17079441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a xenograft glioma model in mouse brain.
    Kaye AH; Morstyn G; Gardner I; Pyke K
    Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.